Shenzhen Readline Biotech Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Shenzhen Readline Biotech Co.,Ltd.

7 YRS

Guangdong, China

CNY 6.5 Million

9990 m²

50-100 people

Main Products: β-Nicotinamide Mononucleotide / Ergothioneine

Guangdong, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturing

Total Employees

50-100 People

Plant Size

15 Acres

Total Annual Revenue

CNY 25 Million

Production Experience

7+ Years

MAIN
PRODUCTS

Nicotinamide Mononucleotide (NMN) / β-Nicotinamide Mononucleotide (β-NMN)

1/6

Nicotinamide Mononucleotide (NMN) / β-Nicotinamide Mononucleotide (β-NMN)

CAS: 1094-61-7

Specification: ≥99.0%(HPLC)

Packing: 25 KG/Fibre Drum

Lead Time: 1-2 weeks

Inquiry

Ergothioneine/L-Ergothioneine/L-Ergothioneine Powder For Skin

1/6

Ergothioneine/L-Ergothioneine/L-Ergothioneine Powder For Skin

CAS: 497-30-3

Specification: ≥99.0%(HPLC)

Packing: 25 KG/Fibre Drum

Lead Time: 1-2 weeks

Inquiry

ABOUT US

Shenzhen Readline Biotech Co.,Ltd.

Founded in 2017, Readline is a high-tech enterprise focusing on the R&D and production of functional healthy raw materials with synthetic biotechnology as its core and multidisciplinary cross-application technology platform as its base. We are committed to building the “ReBioHub” which covers the entire industry chain to promote the integration and innovation of cutting-edge technology fields such as synthetic biology, chemistry, information technology and engineering. We gather multidisciplinary technical resources and innovative elements to build the “ReBioHub”, which covers biocomputing and AI, green chemistry, genetic engineering, enzyme engineering, cell engineering, fermentation engineering, intelligent automation and quality research to promote the integration and innovation in cutting-edge technologies such as synthetic biology, chemistry, IT, engineering. With the mission of “green technology healthy life”, we concentrate on creating innovative products and business solutions in health, consumption and agriculture industries. Through reasonable industrial layout, responsible business practices, all-rounded production and technical services covering the entire industrial chain, we lead industry reform and become a pioneer in achieving the sustainable development goals. We adopt the innovative dual management model of "technology + operation". The core technical team consists of more than 30 talents from the fields of biology, chemistry, materials, enzyme engineering, fermentation engineering, automation, AI, computer science, software engineering, etc. The core operation team is composed of more than 30 senior managers of Fortune 500 or listed companies. Our R&D team accounts for over 60% of the total staff, nearly 50% of whom have master's degree or above, 12% of whom have overseas experience of study or work. Core operation centers: We have multiple functional centers such as R&D, Production, Quality Control, Supply Chain and Marketing. We work together to create value for customers, providing high-quality products and services. We actively fulfill the corporate social responsibility in addressing global health environmental challenges. We integrate sustainability and social values into our business model, take profit growth target, ESG support, synthetic biotechnology implementation and scale production into consideration, accelerate the transformation of raw material manufacturing to the direction of “green, low-carbon and recyclable”. We embed the objectives of corporate social responsibility into strategic perspective and operation system, look beyond the present to the future, and achieve the sustainable development goal of balancing “environment, social and governance” performances through “symbiotic growth” core value system, swift management mode and evolutionary organizational form. We actively share the concepts and practices of corporate social responsibility within the industry, and work together with the government, partners and investors to promote industrial upgrading and social progress.